Jeffrey J. Brown - Jun 20, 2024 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Jun 20, 2024
Transactions value $
$126,465
Form type
4
Date filed
6/24/2024, 05:50 PM
Previous filing
Apr 24, 2024
Next filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $0 +6.6K +114.05% $0.00 12.4K Jun 20, 2024 Direct F1
transaction MED Common Stock Award $126K +5.58K +45.08% $22.66 18K Jun 20, 2024 Direct F2, F3
holding MED Common Stock 4.23K Jun 20, 2024 Jeffrey Brown Living Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.
F2 The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation for annual service as a non-employee director of the Issuer.
F3 This price per share of $22.66 is based on the 20-day moving average stock price of the Issuer's common stock as of June 18, 2024.
F4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.